Impact of the Niemann-Pick c1 Gene Mutation on the Total Cellular Glycomics of CHO Cells

被引:9
|
作者
Furukawa, Jun-ichi [1 ,4 ,5 ]
Soga, Minami [3 ]
Okada, Kazue [1 ,4 ,5 ]
Yokota, Ikuko [1 ,4 ,5 ]
Piao, Jinhua [1 ]
Irie, Tetsumi [3 ]
Era, Takumi [2 ]
Shinohara, Yasuro [1 ,6 ]
机构
[1] Hokkaido Univ, Grad Sch Adv Life Sci, Sapporo, Hokkaido 0010021, Japan
[2] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Cell Modulat, Kumamoto 8600811, Japan
[3] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Clin Chem & Informat, Kumamoto 8620973, Japan
[4] Hokkaido Univ, Fac Med, Dept Adv Clin Glycobiol, Sapporo, Hokkaido 0010021, Japan
[5] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido 0010021, Japan
[6] Kinjo Gakuin Univ, Dept Pharm, Nagoya, Aichi 4638521, Japan
关键词
Niemann-Pick disease; glycomics; N-glycan; O-glycan; glycosaminoglycan; glycosphingolipids; free oligosaccharide; cyclodextrin; DISEASE TYPE-C; N-GLYCOSYLATION; HEPARAN-SULFATE; STORAGE; IDENTIFICATION; ACCUMULATION; BIOMARKERS; MIGLUSTAT; TRANSPORT; CERAMIDE;
D O I
10.1021/acs.jproteome.7b00070
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Niemann-Pick disease type C (NPC) is an autosomal recessive lipid storage disorder, and the majority of cases are caused by mutations in the NPC1 gene. In this study, we clarified how a single gene mutation in the NPC1 gene impacts the cellular glycome by analyzing the total glycomic expression profile of Chinese hamster ovary cell mutants defective in the Npc1 gene (Npc1 KO CHO cells). A number of glycomic alterations were identified, including increased expression of lactosylceramide, GM1, GM2, GD1, various neolacto-series glycosphingolipids, and sialyl-T (O-glycan), which was found to be the major sialylated protein-bound glycan, as well as various N-glycans, which were commonly both fucosylated and sialylated. We also observed significant increases in the total amounts of free oligosaccharides (fOSs), especially in the unique complex- and hybrid-type fOSs. Treatment of Npc1 KO CHO cells with 2-hydroxypropyl-beta-cyclodextrin (HPBCD), which can reduce cholesterol and glycosphingolipid (GSL) storage, did not affect the glycomic alterations observed in the GSL-, N-, and O-glycans of Npc1 KO CHO cells. However, HPBCD treatment corrected the glycomic alterations observed in fOSs to levels observed in wild-type cells.
引用
收藏
页码:2802 / 2810
页数:9
相关论文
共 50 条
  • [1] Current Challenges in Understanding the Cellular and Molecular Mechanisms in Niemann-Pick Disease Type C1
    Braeuer, Anja U.
    Kuhla, Angela
    Holzmann, Carsten
    Wree, Andreas
    Witt, Martin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (18)
  • [2] Necroptosis in Niemann-Pick disease, type C1: a potential therapeutic target
    Cougnoux, A.
    Cluzeau, C.
    Mitra, S.
    Li, R.
    Williams, I.
    Burkert, K.
    Xu, X.
    Wassif, C. A.
    Zheng, W.
    Porter, F. D.
    CELL DEATH & DISEASE, 2016, 7 : e2147 - e2147
  • [3] Identification of cerebral spinal fluid protein biomarkers in Niemann-Pick disease, type C1
    Campbell, Kiersten
    Cawley, Niamh X.
    Luke, Rachel
    Scott, Katelin E. J.
    Johnson, Nicholas
    Farhat, Nicole Y.
    Alexander, Derek
    Wassif, Christopher A.
    Li, Wenping
    Cologna, Stephanie M.
    Berry-Kravis, Elizabeth
    Do, An Dang
    Dale, Ryan K.
    Porter, Forbes D.
    BIOMARKER RESEARCH, 2023, 11 (01)
  • [4] 2-Hydroxypropyl-β-cyclodextrin is the active component in a triple combination formulation for treatment of Niemann-Pick C1 disease
    Davidson, Jessica
    Molitor, Elizabeth
    Moores, Samantha
    Gale, Sarah E.
    Subramanian, Kanagaraj
    Jiang, Xuntian
    Sidhu, Rohini
    Kell, Pamela
    Zhang, Jesse
    Fujiwara, Hideji
    Davidson, Cristin
    Helquist, Paul
    Melancon, Bruce J.
    Grigalunas, Michael
    Liu, Gang
    Salahi, Farbod
    Wiest, Olaf
    Xu, Xin
    Porter, Forbes D.
    Pipalia, Nina H.
    Cruz, Dana L.
    Holson, Edward B.
    Schaffer, Jean E.
    Walkley, Steven U.
    Maxfield, Frederick R.
    Ory, Daniel S.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2019, (10): : 1545 - 1561
  • [5] Cholesterol homeostatic responses provide biomarkers for monitoring treatment for the neurodegenerative disease Niemann-Pick C1 (NPC1)
    Tortelli, Brett
    Fujiwara, Hideji
    Bagel, Jessica H.
    Zhang, Jessie
    Sidhu, Rohini
    Jiang, Xuntian
    Yanjanin, Nicole M.
    Shankar, Roopa Kanakatti
    Carillo-Carasco, Nuria
    Heiss, John
    Ottinger, Elizabeth
    Porter, Forbes D.
    Schaffer, Jean E.
    Vite, Charles H.
    Ory, Daniel S.
    HUMAN MOLECULAR GENETICS, 2014, 23 (22) : 6022 - 6033
  • [6] Hepatocellular carcinoma as a complication of Niemann-Pick disease type C1
    Rodriguez-Gil, Jorge L.
    Bianconi, Simona E.
    Farhat, Nicole
    Kleiner, David E.
    Nelson, Marie
    Porter, Forbes D.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2021, 185 (10) : 3111 - 3117
  • [7] Increased Regenerative Capacity of the Olfactory Epithelium in Niemann-Pick Disease Type C1
    Meyer, Anja
    Wree, Andreas
    Guenther, Rene
    Holzmann, Carsten
    Schmitt, Oliver
    Rolfs, Arndt
    Witt, Martin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (04):
  • [8] Swallowing characterization of adult-onset Niemann-Pick, type C1 patients
    Solomon, Beth I.
    Munoz, Andrea M.
    Sinaii, Ninet
    Mohamed, Hibaaq
    Farhat, Nicole M.
    Alexander, Derek
    Do, An Dang
    Porter, Forbes D.
    ORPHANET JOURNAL OF RARE DISEASES, 2024, 19 (01)
  • [9] Microglia activation in Niemann-Pick disease, type C1 is amendable to therapeutic intervention
    Cougnoux, Antony
    Drummond, Rebecca A.
    Collar, Amanda L.
    Iben, James R.
    Salman, Alexander
    Westgarth, Harrison
    Wassif, Christopher A.
    Cawley, Niamh X.
    Farhat, Nicole Y.
    Ozato, Keiko
    Lionakis, Michail S.
    Porter, Forbes D.
    HUMAN MOLECULAR GENETICS, 2018, 27 (12) : 2076 - 2089
  • [10] Improved neuroprotection using miglustat, curcumin and ibuprofen as a triple combination therapy in Niemann-Pick disease type C1 mice
    Williams, Ian M.
    Wallom, Kern-Lee
    Smith, David A.
    Al Eisa, Nada
    Smith, Claire
    Platt, Frances M.
    NEUROBIOLOGY OF DISEASE, 2014, 67 : 9 - 17